|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 05, 2016 ) The report provides comprehensive information on the therapeutics under development for Depression, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Depression and features dormant and discontinued projects.
Publisher's Depression Healthcare Industry report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Depression
- The report reviews pipeline therapeutics for Depression by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Depression therapeutics and enlists all their major and minor projects
- The report assesses Depression therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
Inquire before Purchasing Report @ http://www.reportsweb.com/inquiry&RW0001231625/buying
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Depression
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Depression pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001231625/sample
Table of Content: An Overview
Introduction 7
Depression Overview 8
Therapeutics Development 9
Depression - Therapeutics under Development by Companies 11
Depression - Therapeutics under Investigation by Universities/Institutes 19
Depression - Pipeline Products Glance 21
Depression - Products under Development by Companies 25
Depression - Products under Investigation by Universities/Institutes 36
Depression - Companies Involved in Therapeutics Development 38
Depression - Therapeutics Assessment 126
Drug Profiles 144
Depression - Recent Pipeline Updates 364
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001231625/discount
List of Tables: An overview
Number of Products under Development for Depression, H1 2016 27
Number of Products under Development for Depression - Comparative Analysis, H1 2016 28
Number of Products under Development by Companies, H1 2016 30
Number of Products under Development by Companies, H1 2016 (Contd..1) 31
Number of Products under Development by Companies, H1 2016 (Contd..2) 32
Number of Products under Development by Companies, H1 2016 (Contd..3) 33
Number of Products under Development by Companies, H1 2016 (Contd..4) 34
Number of Products under Development by Companies, H1 2016 (Contd..5) 35
Number of Products under Development by Companies, H1 2016 (Contd..6) 36
Number of Products under Investigation by Universities/Institutes, H1 2016 38
Comparative Analysis by Late Stage Development, H1 2016 39
Comparative Analysis by Clinical Stage Development, H1 2016 40
Comparative Analysis by Early Stage Development, H1 2016 41
Comparative Analysis by Unknown Stage Development, H1 2016 42
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001231625/buy/2000
About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Email: sales@reportsweb.com
Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
